Secondary Logo

Share this article on:

LONGLEY ROSS E.; CADDIGAN, DIERDRE; HARMODY, DEDRA; GUNASEKERA, MALIKA; GUNASEKERA, SARATH P.
Transplantation: October 1991
ARTICLES: PDF Only

The in vitro immunosuppressive properties of a novel, marine-derived compound, discodermolide, are reported here. Discodermolide suppressed the proliferative responses of splenocytes in the murine two-way mixed lymphocyte reaction (MLR) and concanavalin A stimulated cultures, with IC50 values of 0.24 μM and 0.19 μM, respectively. There was no evidence of cyto-toxicity for murine splenocytes at concentrations of discodermolide as high as 1.26 μM. Similarly, discodermolide suppressed the proliferative responses of human peripheral blood leukocytes (PBL) in the two-way MLR, and Con A and phytohemagglutinin mitogenesis. The IC50 values were 5.65 μM, 28.02 μM, and 30.12 μM for the MLR, Con A, and PHA mitogenic responses, respectively. There was no evidence of cytotozicity toward human PBL at discodermolide concentrations as high as 80.64 μM. Discodermolide was equally effective, compared with cyclosporine, in suppressing the PMA-ionomycin induced proliferation of purified, murine T cells, with IC50 values of 9.0 nM and 14.0 nM for discoder molide and CsA, respectively. The production of IL-2 by PMA-ionomycin stimulated T cells was not inhibited by discodermolide; however, the percentage of IL-2 receptor-bearing cells as measured by immunofluorescence with 7D4 antibody, specific for the 55-kDa chain (p55) comprising the murine IL-2 receptor, was reduced. The expression of a similar chain comprising the human IL-2 receptor (Tac antigen, p55) by PHA or Con-A-stimulated PBL was similarly suppressed by discodermolide. The precise mechanism of action of discodermolide remains to be elucidated.

© Williams & Wilkins 1991. All Rights Reserved.